Medistim ASA (0OCD) Financial Statements
Medistim ASA Financial Overview
Medistim ASA's market cap is currently $5.56B. The company's EPS TTM is $9.74; its P/E ratio is 31.31; and it has a dividend yield of 3.43%. Medistim ASA is estimated to report earnings on February 26, 2027, and the estimated EPS forecast is $2.38. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 699.77M | $ 562.60M | $ 521.11M | $ 486.26M | $ 417.82M |
| Gross Profit | $ 321.19M | $ 448.92M | $ 408.83M | $ 379.78M | $ 320.70M |
| Operating Income | $ 196.20M | $ 131.08M | $ 131.44M | $ 141.25M | $ 116.28M |
| EBITDA | $ 235.77M | $ 155.59M | $ 155.10M | $ 169.72M | $ 138.09M |
| Net Income | $ 159.21M | $ 103.83M | $ 103.82M | $ 113.97M | $ 90.90M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 212.09M | $ 179.21M | $ 153.87M | $ 144.16M | $ 124.87M |
| Total Assets | $ 660.60M | $ 574.97M | $ 505.72M | $ 482.66M | $ 403.24M |
| Total Debt | $ 49.27M | $ 34.36M | $ 17.64M | $ 17.11M | $ 24.19M |
| Net Debt | $ -162.82M | $ -144.85M | $ -128.44M | $ -127.06M | $ -100.67M |
| Total Liabilities | $ 192.19M | $ 138.36M | $ 107.78M | $ 114.97M | $ 97.19M |
| Stockholders' Equity | $ 468.41M | $ 436.61M | $ 397.94M | $ 367.69M | $ 306.05M |
| Cash Flow | |||||
| Free Cash Flow | $ 181.59M | $ 137.04M | $ 83.46M | $ 92.39M | $ 116.65M |
| Operating Cash Flow | $ 187.08M | $ 141.56M | $ 113.19M | $ 113.49M | $ 128.14M |
| Investing Cash Flow | $ -33.01M | $ -24.69M | $ -29.73M | $ -21.10M | $ -11.49M |
| Financing Cash Flow | $ -123.48M | $ -91.53M | $ -84.88M | $ -70.30M | $ -59.05M |
Currency in NOK
